"2019 China-Japan Advanced Medical and New Drug R&D Summit and Achievements Transformation Conference" will be held on November 10, 2019 (On-site registration on Nov. 9) at Shangri-La Hotel, Chengdu. In addition to the summit, the conference will introduce transformation and investment of over 1,000 achievements and products regarding the most advanced medical technology and new drug research of both China and Japan, including over 400 items of regenerative medical products such as stem cell therapy and biomaterials with undergoing or completed clinical trials, various immunotherapy and gene therapy, and other new drug products provided by Japan. The conference will provide a platform for doctors, scientists, entrepreneurs and investors from China and Japan to showcase their achievements, exchange their resources and make investment. People are welcome to provide projects and achievements with display and exchange needs (see below). The conference will provide a free poster for display and exchange for each registered participant and post it on the conference website. During the conference, special events for investment promotion and innovation will be held in Chengdu High-tech Zone, Wenjiang District, Wuhou District, Pengzhou City, Tianfu New Area, etc.

Chengdu, China

With the theme of “Dialogue with top experts, aggregating of leading achievements, sharing investment opportunities, and promoting industrial development”, the conference plans to invite more than 1,000 people including Chinese and Japanese government officials, experts, scholars, entrepreneurs, and representatives from well-known institutions, academies, investment institutions and related companies. Among them, participants from China will include leaders from National Health Commission, National Medical Products Administration, Sichuan Province, and Chengdu, a number of academicians, famous experts, entrepreneurs and investors. Participants from Japan will include head of Health, Labour and Welfare (equivalent to the director of National Medical Products Administration), Nobel Prize winners and dozens of top experts in the field of biomedical research and development in Japan and dozens of large Japanese pharmaceutical companies.

Kobe, Japan

This conference was initiated by Translational Research Center for Medical innovation (TRI) in Japan, a semi-official organization directly under the administration of the Japan Food and Drug Administration. The team is made up of more than 300 experts responsible for coordination and administration of clinical trials, and providing financial support for researchers. The center manages more than one thousand  projects initiated by researchers or R&D companies in Japan's top universities, especially various regenerative medical products such as stem cell therapy, biomaterials, various immunotherapies and gene therapies, and new drug clinical trials. More than 400 items have been approved for clinical trials. The center is under regulated administration, and their data is not only recognized by Japanese drug regulatory departments, but also shared with Europe and America. Many projects are mature and ready for investment transformation and industrialization. PD-1 inventor and 2018 Nobel Prize winner Professor Tasuku Honjo (Kyoto University) acts as president of the center, while Fukushima, former Professor of Kyoto University, acts as the director. In recent years, TRI has actively promoted cooperation and transformation of achievements with local governments, universities, academies, pharmaceutical companies and investment institutions from China, and actively promoted industrial upgrading of Chinese enterprises.

Professor Tasuku Honjo, president of TRI and winner of 2018 Nobel Prize

Tasuku Honjo was born in 1942 in Kyoto, Japan, and graduated from Kyoto University, an immunologist. He was winner of Nobel Prize in Physiology or Medicine in 2018, a foreign academician of the National Academy of Sciences in U.S.A., and a member of the Japanese Academy of Sciences. He is currently a special professor at the School of Advanced Studies of Kyoto University, president of the Shizuoka Public University, and a cultural contributor.

Requirement for Participation Registration and Achievements Display

The conference will provide a free achievement display and exchange poster of about one m² for each registered participant, which will be exhibited during the conference and posted on the conference website after the conference. For needs of larger exhibition areas and booths, please contact the conference organizing team. The projects for the exhibition include various cell therapy, immune and gene therapy, various innovative drugs, medical devices, biomedical materials, diagnostic reagents, various research equipment, and research reagents from home and abroad. Each project requires 300-500 words introduction, including research background, R&D content and progress (with one or two color pictures if needed), intellectual property rights acquired, transformation methods desired, contacts and contact information, and WeChat QR is encouraged. The conference will dock exhibitors with a number of local government industrial parks, hundreds of pharmaceutical companies and large-scale investment institutions, and actively promote achievement transformation and project settlement.

In order to ensure the orderly preparations for the conference, the conference will charge different conference registration fees in the form of a ladder price. The registration fee for a single participant is 3,000 yuan, while for a group of two or more people it is 2,500 yuan / person. Note: Upon registration and payment completion, no registration fee refund is applicable for the participants’ absence from the conference. But a substitute person is allowed for the participation where he/she can register with the letter of consent (signed by the original applicant) and copies of the letter/screenshot of original registration and payment confirmation.

Please scan the QR below for registration details.

Or click “Read the Article" at the end of the text

http://cjs2019.medmeeting.org/Content/144728 (for computer user)

Scan QR

Enter the registration page

View more conference information 

E-mail: wuzhenhao@scimea.cn

Tel: 028-63859818

Contact: Mr. Wu 18828050676

Address of conference organizing committee:

507-1, Building 10, Thinkzone, 399 West Section of Fucheng Avenue, High-tech Zone